These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 5033012)

  • 21. Active transport of 5-hydroxyindoleacetic acid by the rabbit choroid plexus in vitro. Blockade by probenecid and metabolic inhibitors.
    Forn J
    Biochem Pharmacol; 1972 Mar; 21(5):619-24. PubMed ID: 5021586
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of monoamine oxidase inhibition on biliary excretion of metabolites of norepinephrine by isolated rat liver.
    Zimon RP; Tyce GM; Flock EV; Sheps SG; Owen CA
    J Pharmacol Exp Ther; 1967 Jul; 157(1):89-95. PubMed ID: 4382102
    [No Abstract]   [Full Text] [Related]  

  • 23. Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
    Ridges AP
    Postgrad Med J; 1976; 52(3 suppl):9-17. PubMed ID: 785425
    [No Abstract]   [Full Text] [Related]  

  • 24. Distribution and turnover rate of vanillylmandelic acid and 3-methoxy-4-hydroxyphenylglycol in rat brain.
    Karoum F; Neff NH; Wyatt RJ
    J Neurochem; 1976 Jul; 27(1):33-5. PubMed ID: 956848
    [No Abstract]   [Full Text] [Related]  

  • 25. [The analysis of catecholamines and some of their degradation products in urine and plasma (author's transl)].
    Wisser H; Knoll E
    Z Klin Chem Klin Biochem; 1973 Jan; 11(1):3-14. PubMed ID: 4804139
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduction of norepinephrine turnover by serotonergic drug in man.
    Rudorfer MV; Scheinin M; Karoum F; Ross RJ; Potter WZ; Linnoila M
    Biol Psychiatry; 1984 Feb; 19(2):179-93. PubMed ID: 6201198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo studies of the metabolism of norepinephrine in the central nervous system.
    Maas JW; Landis DH
    J Pharmacol Exp Ther; 1968 Sep; 163(1):147-62. PubMed ID: 5673702
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of morphine metabolism by catechol in the chicken kidney.
    Watrous WM; Fujimoto JM
    Biochem Pharmacol; 1971 Jul; 20(7):1479-91. PubMed ID: 5126486
    [No Abstract]   [Full Text] [Related]  

  • 29. Catabolism of epinephrine- 14 C by American chameleons (Anolis carolinensis).
    Scott JL; Neudeck LD
    Gen Comp Endocrinol; 1972 Feb; 18(1):37-42. PubMed ID: 5009676
    [No Abstract]   [Full Text] [Related]  

  • 30. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate.
    Greenspan K; Schildkraut JJ; Gordon EK; Baer L; Aronoff MS; Durell J
    J Psychiatr Res; 1970 Feb; 7(3):171-83. PubMed ID: 5440858
    [No Abstract]   [Full Text] [Related]  

  • 31. Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs.
    Junod AF
    J Pharmacol Exp Ther; 1972 Nov; 183(2):341-55. PubMed ID: 5083550
    [No Abstract]   [Full Text] [Related]  

  • 32. On the origin of vanillylmandelic acid and 3-methoxy-4-hydroxy-phenylglycol in the rat brain.
    Adèr JP; Muskiet FA; Jeuring HJ; Korf J
    J Neurochem; 1978 Jun; 30(6):1213-6. PubMed ID: 670965
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of delta9-tetrahydrocannabinol on the metabolism of 3H-5-hydroxytryptamine and 3H-norepinephrine in the rat brain.
    Ho BT; Taylor D; Englert LF
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):645-50. PubMed ID: 4828760
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid.
    Gordon EK; Oliver J; Goodwin FK; Chase TN; Post RM
    Neuropharmacology; 1973 Apr; 12(4):391-6. PubMed ID: 4703880
    [No Abstract]   [Full Text] [Related]  

  • 35. Site of excretion of catechol and catecholamines: renal metabolism of catechol.
    Rennick B; Quebbemann A
    Am J Physiol; 1970 May; 218(5):1307-12. PubMed ID: 5438255
    [No Abstract]   [Full Text] [Related]  

  • 36. The rate of formation of 3-methoxy-4-hydroxyphenylethyleneglycol sulfate in brain as an estimate of the rate of formation of norepinephrine.
    Meek JL; Neff NH
    J Pharmacol Exp Ther; 1973 Mar; 184(3):570-5. PubMed ID: 4687220
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.
    Neef NH; Tozer TN; Brodie BB
    J Pharmacol Exp Ther; 1967 Nov; 158(2):214-8. PubMed ID: 6065144
    [No Abstract]   [Full Text] [Related]  

  • 38. Acetaldehyde mediation in the mechanism of ethanol-induced changes in norepinephrine metabolism.
    Walsh MJ; Truitt EB; Davis VE
    Mol Pharmacol; 1970 Jul; 6(4):416-24. PubMed ID: 5429284
    [No Abstract]   [Full Text] [Related]  

  • 39. Sources and significance of plasma levels of catechols and their metabolites in humans.
    Goldstein DS; Eisenhofer G; Kopin IJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human norepinephrine metabolism. Its evaluation bydministration of tritiated norepinephrine.
    Gitlow SE; Mendlowitz M; Bertani LM; Wilk S; Wilkek
    J Clin Invest; 1971 Apr; 50(4):859-65. PubMed ID: 5547279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.